• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Sandra J. Lee, ScD


  • Stout NK, Lee SJ, Schechter CB, Kerlikowske K, Alagoz O, Berry D, Buist DS, Cevik M, Chisholm G, de Koning HJ, Huang H, Hubbard RA, Miglioretti DL, Munsell MF, Trentham-Dietz A, van Ravesteyn NT, Tosteson AN, Mandelblatt JS.Benefits, Harms, and Costs for Breast Cancer Screening After US Implementation of Digital Mammography.Journal of the National Cancer Institute. 2014 Jun;106(6).
  • Wilson MA, Zhao F, Letrero R, D'Andrea K, Rimm DL, Kirkwood JM, Kluger HM, Lee SJ, Schuchter LM, Flaherty KT, Nathanson KL.Correlation of somatic mutations and clinical outcome in melanoma patients treated with carboplatin, paclitaxel, and sorafenib.Clin Cancer Res. 2014 Apr 8.
  • Flaherty KT, Hennig M, Lee SJ, Ascierto PA, Dummer R, Eggermont AM, Hauschild A, Kefford R, Kirkwood JM, Long GV, Lorigan P, Mackensen A, McArthur G, O'Day S, Patel PM, Robert C, Schadendorf D.Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials.Lancet Oncol. 2014 Mar;15(3):297-304.
  • Tarhini AA, Shin D, Lee SJ, Stuckert J, Sander CA, Kirkwood JM.Serologic evidence of autoimmunity in E2696 and E1694 patients with high-risk melanoma treated with adjuvant interferon alfa.Melanoma Res. 2014 Apr;24(2):150-7.
  • Averbook BJ, Lee SJ, Delman KA, Gow KW, Zager JS, Sondak VK, Messina JL, Sabel MS, Pittelkow MR, Ecker PM, Markovic SN, Swetter SM, Leachman SA, Testori A, Curiel-Lewandrowski C, Go RS, Jukic DM, Kirkwood JM.Pediatric melanoma: analysis of an international registry.Cancer. 2013 Nov 15;119(22):4012-9.
  • Go RS, Lee SJ, Shin D, Callister SM, Jobe DA, Conry RM, Tarhini AA, Kirkwood JM.ECOG phase II trial of graded-dose peginterferon α-2b in patients with metastatic melanoma overexpressing basic fibroblast growth factor (E2602).Clin Cancer Res. 2013 Dec 1;19(23):6597-604.
  • Karp DD, Lee SJ, Keller SM, Wright GS, Aisner S, Belinsky SA, Johnson DH, Johnston MR, Goodman G, Clamon G, Okawara G, Marks R, Frechette E, McCaskill-Stevens W, Lippman SM, Ruckdeschel J, Khuri FR.Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597.J Clin Oncol. 2013 Nov 20;31(33):4179-87.
  • Jilaveanu LB, Zhao F, Zito CR, Kirkwood JM, Nathanson KL, D'Andrea K, Wilson M, Rimm DL, Flaherty KT, Lee SJ, Kluger HM.Expression of drug targets in patients treated with sorafenib, Carboplatin and Paclitaxel.PLoS ONE. 2013;8(8):e69748.
  • Slingluff CL, Lee S, Zhao F, Chianese-Bullock KA, Olson WC, Butterfield LH, Whiteside TL, Leming PD, Kirkwood JM.A Randomized Phase II Trial of Multi-epitope Vaccination withMelanoma Peptides for Cytotoxic T-Cells and Helper T-Cells forPatients with Metastatic Melanoma (E1602).Clin Cancer Res. 2013 May 7.
  • Flaherty KT, Lee SJ, Zhao F, Schuchter LM, Flaherty L, Kefford R, Atkins MB, Leming P, Kirkwood JM.Phase III trial of carboplatin and paclitaxel with or without sorafenib in metastatic melanoma.J Clin Oncol. 2013 Jan 20;31(3):373-9.
  • Arvold ND, Punglia RS, Hughes ME, Jiang W, Edge SB, Javid SH, Laronga C, Niland JC, Theriault RL, Weeks JC, Wong YN, Lee SJ, Hassett MJ.Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ.Cancer. 2012 Jun 6.
  • Cianfrocca M, Lee S, Von Roenn J, Rudek MA, Dezube BJ, Krown SE, Sparano JA.Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi's sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial.Cancer Chemother Pharmacol. 2011 Jan 5.
  • Cianfrocca M, Lee S, Von Roenn J, Tulpule A, Dezube BJ, Aboulafia DM, Ambinder RF, Lee JY, Krown SE, Sparano JA.Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy.Cancer. 2010 Aug 15;116(16):3969-77.
  • Rao UN, Lee SJ, Luo W, Mihm MC, Kirkwood JM.Presence of tumor-infiltrating lymphocytes and a dominant nodule within primary melanoma are prognostic factors for relapse-free survival of patients with thick (t4) primary melanoma: pathologic analysis of the e1690 and e1694 intergroup trials.Am J Clin Pathol. 2010 Apr;133(4):646-53.
  • Chenine AL, Siddappa NB, Kramer VG, Sciaranghella G, Rasmussen RA, Lee SJ, Santosuosso M, Poznansky MC, Velu V, Amara RR, Souder C, Anderson DC, Villinger F, Else JG, Novembre FJ, Strobert E, O'Neil SP, Evan Secor W, Ruprecht RM.Relative Transmissibility of an R5 Clade C Simian-Human Immunodeficiency Virus Across Different Mucosae in Macaques Parallels the Relative Risks of Sexual HIV-1 Transmission in Humans via Different Routes.J Infect Dis. 2010 Apr 15;201(8):1155-63.
  • Litzow MR, Othus M, Cripe LD, Gore SD, Lazarus HM, Lee SJ, Bennett JM, Paietta EM, Dewald GW, Rowe JM, Tallman MS, .Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group.British Journal of Haematology. 2010 Jan;148(2):217-25.
  • Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, Huang H, Lee SJ, Munsell M, Plevritis SK, Ravdin P, Schechter CB, Sigal B, Stoto MA, Stout NK, van Ravesteyn NT, Venier J, Zelen M, Feuer EJ, .Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.Ann Intern Med. 2009 Nov 17;151(10):738-47.
  • Mirshahidi S,Kramer VG,Whitney JB,Essono S,Lee S,Dranoff G,Anderson KS,Ruprecht RM.Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survival.Vaccine. 2009 Mar 13;27(12):1825-33.
  • Jilaveanu L,Zito C,Lee SJ,Nathanson KL,Camp RL,Rimm DL,Flaherty KT,Kluger HM.Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenib.Clin Cancer Res. 2009 Feb 1;15(3):1076-85.
  • Wu Y,Navarro F,Lal A,Basar E,Pandey RK,Manoharan M,Feng Y,Lee SJ,Lieberman J,Palliser D.Durable protection from Herpes Simplex Virus-2 transmission following intravaginal application of siRNAs targeting both a viral and host gene.Cell Host Microbe. 2009 Jan 22;5(1):84-94.
  • Atkins MB,Hsu J,Lee S,Cohen GI,Flaherty LE,Sosman JA,Sondak VK,Kirkwood JM.Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group.J Clin Oncol. 2008 Dec 10;26(35):5748-54.
  • Lee SJ, Zelen M.Mortality Modeling of Early Detection Programs.Biometrics. 2008 Jun;64(2):386-95.
  • Korn EL, Liu PY, Lee SJ, Chapman JA, Niedzwiecki D, Suman VJ, Moon J, Sondak VK, Atkins MB, Eisenhauer EA, Parulekar W, Markovic SN, Saxman S, Kirkwood JM.Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials.J Clin Oncol. 2008 Feb 1;26(4):527-34.
  • Treister NS, Cook EF Jr, Antin J, Lee SJ, Soiffer R, Woo SB.Clinical evaluation of oral chronic graft-versus-host disease.Biol Blood Marrow Transplant. 2008 Jan;14(1):110-5.
  • Ballen KK, Spitzer TR, Yeap BY, McAfee S, Dey BR, Attar E, Haspel R, Kao G, Liney D, Alyea E, Lee S, Cutler C, Ho V, Soiffer R, Antin JH.Double unrelated reduced-intensity umbilical cord blood transplantation in adults.Biol Blood Marrow Transplant. 2007 Jan;13(1):82-9.
  • Brown JR, Kim HT, Li S, Stephans K, Fisher DC, Cutler C, Ho V, Lee SJ, Milford EL, Ritz J, Antin JH, Soiffer RJ, Gribben JG, Alyea EP.Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia.Biol Blood Marrow Transplant. 2006 Oct;12(10):1056-64.
  • Lee S, Zelen M.A stochastic model for predicting the mortality of breast cancer.J Natl Cancer Inst Monogr. 2006(36):79-86.
  • Litzow MR, Lee S, Bennett JM, Dewald GW, Gallagher RE, Jain V, Paietta EM, Racevskis J, Rousey SR, Mazza JJ, Tallman MS.A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia.Haematologica. 2006 Aug;91(8):1105-8.
  • Ho VT, Kim HT, Liney D, Milford E, Gribben J, Cutler C, Lee SJ, Antin JH, Soiffer RJ, Alyea EP.HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation.Bone Marrow Transplant. 2006 May;37(9):845-50.
  • Cutler C, Henry NL, Magee C, Li S, Kim HT, Alyea E, Ho V, Lee SJ, Soiffer R, Antin JH.Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant. 2005 Jul;11(7):551-7.
  • Zorn E, Kim HT, Lee SJ, Floyd BH, Litsa D, Arumugarajah S, Bellucci R, Alyea EP, Antin JH, Soiffer RJ, Ritz J.Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.Blood. 2005 Oct 15;106(8):2903-11.
  • Lee SJ, Joffe S, Kim HT, Socie G, Gilman AL, Wingard JR, Horowitz MM, Cella D, Syrjala KL.Physicians' attitudes about quality of life issues in hematopoietic stem cell transplantation.Blood. 2004 Oct 1;104(7):2194-200.
  • Sekeres MA, Stone RM, Zahrieh D, Neuberg D, Morrison V, De Angelo DJ, Galinsky I, Lee SJ.Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome.Leukemia. 2004 Apr;18(4):809-16.
  • Lee SJ, Zelen M.Modelling the early detection of breast cancer.Ann Oncol. 2003 Aug;14(8):1199-202.
  • Akpek G, Lee SJ, Flowers ME, Pavletic SZ, Arora M, Lee S, Piantadosi S, Guthrie KA, Lynch JC, Takatu A, Horowitz MM, Antin JH, Weisdorf DJ, Martin PJ, Vogelsang GB.Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study.Blood. 2003 Aug 1;102(3):802-9.
  • Galper SR, Lee SJ, Tao ML, Troyan S, Kaelin CM, Harris JR, Weeks JC.Patient preferences for axillary dissection in the management of early-stage breast cancer.J Natl Cancer Inst. 2000 Oct 18;92(20):1681-7.
  • Lee SJ, Zelen M.Clinical trials and sample size considerations: another perspective.Statistical Science. 2000 May 01;15(2):95-110.
  • Schorge JO, Muto MG, Lee SJ, Huang LW, Welch WR, Bell DA, Keung EZ, Berkowitz RS, Mok SC.BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis.Cancer Res. 2000 Mar 1;60(5):1361-4.
  • Lee SJ, Klar N, Weeks JC, Antin JH.Predicting costs of stem-cell transplantation.J Clin Oncol. 2000 Jan;18(1):64-71.
  • Tai YT, Lee S, Niloff E, Weisman C, Strobel T, Cannistra SA.BAX protein expression and clinical outcome in epithelial ovarian cancer.J Clin Oncol. 1998 Aug;16(8):2583-90.
  • Zerez CR, Lachant NA, Lee SJ, Tanaka KR.Decreased erythrocyte nicotinamide adenine dinucleotide redox potential and abnormal pyridine nucleotide content in sickle cell disease.Blood. 1988 Feb;71(2):512-5.
  • Zerez CR, Lee SJ, Tanaka KR.Spectrophotometric determination of oxidized and reduced pyridine nucleotides in erythrocytes using a single extraction procedure.Anal Biochem. 1987 Aug 1;164(2):367-73.